These meta-analyses found no statistically significant differences between the efficacy of propranolol and benzodiazepines regarding the short-term treatment of panic disorder with or without agoraphobia .
Also , no evidence was found for effects of propranolol on PTSD symptom severity through inhibition of memory reconsolidation .
In conclusion , the quality of evidence for the efficacy of propranolol at present is insufficient to support the routine use of propranolol in the treatment of any of the anxiety disorders
The effects of propranolol in the treatment of anxiety disorders have not been systematic ally evaluated previously .
The aim was to conduct a systematic review and meta- analysis of r and omised controlled trials , addressing the efficacy of oral propranolol versus placebo or other medication as a treatment for alleviating either state or trait anxiety in patients suffering from anxiety disorders .
A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients.
We studied the efficacy of propranolol ( Inderal ) compared to alprazolam ( Xanax ) in 29 patients with a diagnosis of agoraphobia with panic disorder or panic disorder with or without limited phobic avoidance in a 6-week double-blind controlled experiment . Alprazolam is effective in those syndromes , whereas to date only negative or ambiguous results had been reported for propranolol .  Fourteen patients received a mean daily dose of 5.0 + /- 2.3 mg of alprazolam and 15 patients received 182.0 + /- 60.5 mg mean daily dose of propranolol . We found both drugs to be effective to suppress panic attacks and reduce avoidance behavior . The only significant between-drug difference was a more rapid onset of alprazolam 's panicolytic effect .  Propranolol merits further study . We suggest patients worthy of a clinical trial
These meta-analyses found no statistically significant differences between the efficacy of propranolol and benzodiazepines regarding the short-term treatment of panic disorder with or without agoraphobia .
Also , no evidence was found for effects of propranolol on PTSD symptom severity through inhibition of memory reconsolidation .
In conclusion , the quality of evidence for the efficacy of propranolol at present is insufficient to support the routine use of propranolol in the treatment of any of the anxiety disorders
The effects of propranolol in the treatment of anxiety disorders have not been systematic ally evaluated previously .
The aim was to conduct a systematic review and meta- analysis of r and omised controlled trials , addressing the efficacy of oral propranolol versus placebo or other medication as a treatment for alleviating either state or trait anxiety in patients suffering from anxiety disorders .